Request Deal Involvement
Journey Medical to acquire the molecule stabilizing technology of VYNE Therapeutics for $475m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Skadden Arps Slate Meagher & Flom
financial advisors
Guggenheim Partners
pr advisors
LifeSci Partners
or
Principals
vendor
VYNE THERAPEUTICS INC
target
VYNE THERAPEUTICS (MOLECULE STABILIZATION TECHNOLOGY)
bidder
JOURNEY MEDICAL CORPORATION
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite